<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report three patients with blastic natural killer (NK)-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of the skin associated with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) (two patients) or <z:hpo ids='HP_0011011'>subacute</z:hpo> <z:mpath ids='MPATH_501'>myelomonocytic leukaemia</z:mpath> (one patient) </plain></SENT>
<SENT sid="1" pm="."><plain>In two patients <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> was diagnosed before <z:mp ids='MP_0001212'>skin lesions</z:mp>; the patient with <z:mpath ids='MPATH_336'>leukaemia</z:mpath> initially presented with <z:mp ids='MP_0001212'>skin lesions</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Our patients had several clinical features in common, namely multiple <z:mp ids='MP_0001212'>skin lesions</z:mp> with a <z:mp ids='MP_0009275'>bruise</z:mp>-like appearance, involvement of the oral mucosa, and good general status at presentation but very rapid deterioration in the course of the disease </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients died of disease 4-14 months after the diagnosis </plain></SENT>
<SENT sid="4" pm="."><plain>Histopathologically, there were cutaneous infiltrates of slightly pleomorphic medium-sized cells expressing CD4, CD56, terminal deoxynucleotidyl transferase (focally) and being negative for surface CD3, cytotoxic molecules, B-cell-associated markers and myelomonocytic markers </plain></SENT>
<SENT sid="5" pm="."><plain>Erythrocyte extravasation was seen in <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="6" pm="."><plain>T-cell receptor genes were in germline configuration </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> was classified as refractory cytopenia with multilineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and ring sideroblasts and refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with transition to refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with excess of blasts </plain></SENT>
<SENT sid="8" pm="."><plain>We reviewed similar cases reported in the literature showing coexistence of blastic NK-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>/<z:mpath ids='MPATH_336'>leukaemia</z:mpath> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> or myelogenous <z:mpath ids='MPATH_336'>leukaemia</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>We conclude that given an overall limited number of reported cases of blastic NK-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>/<z:mpath ids='MPATH_336'>leukaemia</z:mpath>, its association with various myelodysplastic/<z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> seen in a subset of patients ( approximately 15-20%) is more than coincidental and may indicate their common origin </plain></SENT>
</text></document>